Frankfurt Oncology 2020-Organizing Committee Members Announcement

Stefan Glueck

Editorial - Journal of Clinical Oncology and Cancer Research (2019) Volume 2, Issue 1

Frankfurt Oncology 2020-Organizing Committee Members Announcement

Stefan Glueck

Vice President Of Global Medical Affairs, E-mail: sgluck@celgene.com

Visit for more related articles at Journal of Clinical Oncology and Cancer Research

Abstract

We are overwhelmed in announcing the first line up of Organizing Committee Members (OCM) of 15th Global Summit on Oncology and Cancer which is scheduled at London, U.K, on June 8-9, 2020 which will be centered and focused with the theme of “Ray of Hope on Bridging Cancer Research and Treatment”.

Oncology 2020 aims at innovating and developing new ideas for the next generation cancer treatment by gathering experts all around the globe and providing a platform to discuss the latest research and innovations in the field of Oncology and Cancer, exploring the novel techniques and new ideas in Cancer diagnosis.

The worldwide renowned Organizing Committee Members of Oncology 2020 are,

Stefan Glueck, Vice President of Global Medical Affairs at Celgene Corporation since October 2014 and a medical oncologist with a focus on Breast Cancer. Previously he served as Sylvester distinguished Professor in the Department of Medicine at Miller School of Medicine, University of Miami, Florida. He was a Clinical Director of the Braman Family Breast Cancer Institute and Assistant Director of Sylvester Comprehensive Cancer Care Centre from 2003-2008 and Associate Chief for the Division of Hematology and Medical Oncology from January 2009-December 2010. Also he has published 275 manuscripts in peer reviewed international journals.

Philip Stroebel, Director of Institute of Pathology, Suttgart, Germany. He has done nearly 290 research work in the field of Pathology and Medicine. A few key research papers are, SPARC dependent collagen deposition and gemcitabine delivery in a genetically engineered mouse model of pancreas cancer and Proteomic Comparison of Malignant Human Germ Cell Tumour Cell Lines.

Jan Jacques Michiels, founder of Blood Coagulation and Vascular Medicine, Good heart Institute and Foundation in Nature Medicine and Health, Netherland. He has published more than 400 original manuscripts in peer-reviewed International Medical Journals. He served as Guest Editor and was the Founder of Thrombocythemia Vera Study Group and also he is the founder and chair of International Collaboration and Academic Research of Myeloproliferative Neoplasms. He is the co-founder of the Central European Vascular Forum (CEVF) and allied Thrombosis Research Group.

Caspar Haule, General Surgeon and Head of Breast Unit at Muhimbili National Hospital, Tanzania. He holds seven years of experience as General Surgeon and Breast Surgeon and he is a member of the Medical Association of Tanzania (MAT) and Tanzania Surgical Associations. The key research papers of Dr.Haule are Efficacy of water-soluble contrast medium (Gastrografin) compared with standard conservative treatment in the management of adhesive small bowel obstruction at a Tertiary Hospital and Association between changes in the serum 25-hydroxyvitamin D level and survival in breast cancer patients receiving neoadjuvant chemotherapy.

Inés Llamas-Ramos, Executive Editor and Physiotherapist at Salamanca, Spain. She started her Physiotherapist at Medical Centre in Malgart, Benavente. She served as Associate Professor of the University of Salamanca, later she started her new position as Asprodes in Salamanca. At present, she is the Physiotherapist at Hyega Physiotherapy in Salamanca, Spain.

To know more visit https://oncology-summit.alliedacademies.com/

Previous Conference Photos - http://oncology -summit.alliedacademies.com/2019/images

Conference Contact:

David Thomas

Program Manager | Oncology 2020

Whatsapp: +441258650017

Email:oncology@tumorconferences.com/oncology@alliedgather.com

15th Global Summit on Oncology and Cancer

June 8-9, 2020
London, U.K